Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

2014 ESC/EACTS Guidelines on myocardial revascularization

(2014)   EUROPEAN HEART JOURNAL

Impact of Gene Polymorphisms, Platelet Reactivity, and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

(2014) Tullio Palmerini et al.   JACC-Cardiovascular Interventions

World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI

(2014) Glenn N. Levine et al.   Nature Reviews Cardiology

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention

(2013) Dániel Aradi et al.   EUROPEAN HEART JOURNAL

Clinical Implications of Very Low On-Treatment Platelet Reactivity in Patients Treated With Thienopyridine

(2013) Thomas Cuisset et al.   JACC-Cardiovascular Interventions

TCT-152 Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study

(2013) Ajay J. Kirtane et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

(2013) Udaya S. Tantry et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

(2013) Gregg W Stone et al.   LANCET

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

(2012) Jolanta M. Siller-Matula et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention

(2012) Fabio Mangiacapra et al.   JACC-Cardiovascular Interventions

Prognostic Value of a High On-Clopidogrel Treatment Platelet Reactivity in Bivalirudin Versus Abciximab Treated Non–ST-Segment Elevation Myocardial Infarction Patients

(2012) Dirk Sibbing et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents

(2012) Dietmar Trenk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel

(2012) L. BONELLO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study

(2012) J. M. SILLER-MATULA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting

(2012) Jean-Philippe Collet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention

(2012) D. Aradi et al.   THROMBOSIS AND HAEMOSTASIS

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)

(2011) Giuseppe Patti et al.   AMERICAN JOURNAL OF CARDIOLOGY

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

(2011) P. G. Steg et al.   EUROPEAN HEART JOURNAL

Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

(2011) Matthew J. Price   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel

(2011) Olivier Morel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention

(2011) Gianluca Campo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events

(2011) Matthias K. Freynhofer et al.   THROMBOSIS AND HAEMOSTASIS

Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

(2010) Nicoline J. Breet   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients

(2010) Dirk Sibbing et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay

(2009) Rossella Marcucci et al.   CIRCULATION

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

(2009) D. SIBBING et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention

(2008) Giuseppe Patti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY